Categories: All postsSoftware

Constellation Software has become too expensive, this portfolio manager says

Michael Simpson

Canadian tech favourite Constellation Software (Constellation Software News, Stock Quote, Chart TSX:CSU) has posted impressive gains over the first half of the year, including a string of new highs hit over the past two months.

So what’s not to like about CSU? The multiples, for one thing, says Michael Simpson, senior vice-president and senior portfolio manager at Sentry Investments, who advises investors to stay away until the stock cools off.

Constellation Software is up an impressive 42 per cent for 2019, with the stock easing into a nice uptrend of late, hitting higher highs and higher lows since February. But posting healthy returns is nothing new for CSU, which has been a top performer on the TSX for a good decade now —who wouldn’t want to have owned Constellation when it was $30.00 back in April of 2009?

But count Simpson among the skeptics who see darker days ahead for this growth stock.

“This is a company that has been around for a while. They consolidate different software companies and they’ve got a number of verticals,” says Simpson, to BNN Bloomberg on Thursday. “Pretty good balance sheet. Our read is no debt.”

“[But] the market is fixated on growth — in Canada certain investors like growth by acquisition stories,” he said. “[Constellation] trades at about 27x earnings and about 20x price to cash flow, so we just find it too rich for our valuation.”

In its favour, CSU has relatively low volatility for a tech stock, while the company has been consistently growing its top and bottom lines over the years. For 2017 and 2018, for example, Constellation grew its revenue by 17 per cent and 23 per cent, respectively, with three per cent organic growth in 2017 and two per cent in 2018. The company’s adjusted EBITA grew by 17 per cent to $621 million in 2017 and then grew by another 22 per cent to $757 million over 2018.

Yet, Simpson feels that along with being a pricey stock, the company’s business model is puzzling.

“Part of their model is that they leave the individual software companies so that there’s no consolidation of centralized services and we find that a bit odd,” said Simpson. “[With] other software companies that consolidate, you can get much higher margins.”

“They’ve done well over the years, but unless their valuation comes down, we’re not going to invest in it,” he said.

More Cantech Software

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

5 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

8 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

8 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

9 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago